.webp&w=384&q=75){kind=logo}
Loading, please wait...
Loading, please wait...
Home and remote blood-pressure monitoring can make hypertension management more responsive by increasing the frequency and reliability of measurements available to clinicians. Randomized studies of telemonitoring combined with pharmacist or clinician management have shown that patients can achieve better blood-pressure control than with usual care. The practical value lies in creating a feedback loop: readings are transmitted, reviewed, medication is adjusted and the patient receives reinforcement without waiting for the next clinic visit. For internal medicine, this model is particularly attractive for patients with high cardiovascular risk, variable office readings or difficulty attending frequent appointments. Technology alone, however, is not the intervention. Accurate cuff selection, validated devices, patient training and a defined clinician-response pathway are necessary. Digital exclusion and connectivity also need to be considered, especially in older or resource-constrained populations. The evidence supports remote monitoring as a complement to—not a replacement for—clinical assessment. Its greatest potential may be in shortening the time between recognizing uncontrolled blood pressure and intensifying treatment, converting hypertension care from periodic measurement into a continuous management process.
Read summarized clinical updates, watch expert medical content, and earn CME certifications right from your smartphone.
Open your smartphone camera to scan and install.
Home and remote blood-pressure monitoring can make hypertension management more responsive by increasing the frequency and reliability of measurements available to clinicians. Randomized studies of telemonitoring combined with pharmacist or clinician management have shown that patients can achieve better blood-pressure control than with usual care. The practical value lies in creating a feedback loop: readings are transmitted, reviewed, medication is adjusted and the patient receives reinforcement without waiting for the next clinic visit. For internal medicine, this model is particularly attractive for patients with high cardiovascular risk, variable office readings or difficulty attending frequent appointments. Technology alone, however, is not the intervention. Accurate cuff selection, validated devices, patient training and a defined clinician-response pathway are necessary. Digital exclusion and connectivity also need to be considered, especially in older or resource-constrained populations. The evidence supports remote monitoring as a complement to—not a replacement for—clinical assessment. Its greatest potential may be in shortening the time between recognizing uncontrolled blood pressure and intensifying treatment, converting hypertension care from periodic measurement into a continuous management process.
4 weeks back
A bioengineered oral nanozyme microsupplement converts pathological ROS into a protective polydopamine hydrogel shield. By curbing neutrophil extracellular traps and balancing T cells, this platform outperforms standard 5-ASA in preclinical colitis models, opening new paths for sustained remission.
4 days back
Recent research reveals that downregulating YAP1/TAZ-TEAD via Hippo signaling triggers spontaneous human trophoblast syncytialization in 3D cultures, illuminating placental biology and preeclampsia.
4 weeks back
Abdominal aortic aneurysm rupture remains a catastrophic vascular emergency. Groundbreaking research reveals that USP53 accelerates aneurysm progression by reprogramming smooth muscle cell metabolism toward aerobic glycolysis, highlighting a promising target beyond conventional diameter-based surveillance.
5 days back
A breakthrough study leverages natural language processing to accurately identify incident medication-related osteonecrosis of the jaw and track antiresorptive drug holidays from clinical narratives in electronic health records, advancing osteoporosis pharmacovigilance and dental safety.
4 days back
Recent research defines ferro-aging as a conserved iron-lipid axis driving organ decline across primates. Age-related iron dyshomeostasis stimulates ACSL4-mediated lipid peroxidation, promoting cellular senescence. Notably, vitamin C directly inhibits ACSL4, suppressing phospholipid oxidation and multi-organ decay.
5 days back
